Hot Selling Biotech Companies (NASDAQ:ILMN, NASDAQ:PACB, NASDAQ:FLDM)

New York, NY -- (SBWIRE) -- 01/20/2014 -- Illumina, Inc. (NASDAQ:ILMN) reported EPS of 0.838. For the Current Fiscal year, the company is expected to report EPS of 1.78. For the Next Quarter and Next Year, the company is expected to report EPS of 0.48 and 2.05 respectively. At Current Market Price, ILMN is in distance of +26.32% from its 50-day Moving Average price of $107.931 and +53.00% from its 200-day Moving Average price of $89.1122.